BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 10505037)

  • 41. Microbiological spectrum and susceptibility patterns of pathogens causing bacteraemia in paediatric febrile neutropenic oncology patients: comparison between two consecutive time periods with use of different antibiotic treatment protocols.
    Greenberg D; Moser A; Yagupsky P; Peled N; Hofman Y; Kapelushnik J; Leibovitz E
    Int J Antimicrob Agents; 2005 Jun; 25(6):469-73. PubMed ID: 15890499
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Gram-negative organisms predominate in Hickman line-related infections in non-neutropenic patients with hematological malignancies.
    Chee L; Brown M; Sasadeusz J; MacGregor L; Grigg AP
    J Infect; 2008 Apr; 56(4):227-33. PubMed ID: 18342947
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Microbiology difference between colonized catheters and catheter-related bloodstream infections.
    Lin C; Lin MT; Hsieh DY; Chao YF; Yeh SL; Wu MS; Lin JT; Lee PH; Chang KJ; Chen WJ
    Hepatogastroenterology; 2003; 50(54):1821-4. PubMed ID: 14696413
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Development and validation of a clinical model to predict the presence of β-lactam resistance in viridans group streptococci causing bacteremia in neutropenic cancer patients.
    Shelburne SA; Lasky RE; Sahasrabhojane P; Tarrand JT; Rolston KV
    Clin Infect Dis; 2014 Jul; 59(2):223-30. PubMed ID: 24755857
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Global prevalence of carbapenem resistance in neutropenic patients and association with mortality and carbapenem use: systematic review and meta-analysis.
    Righi E; Peri AM; Harris PN; Wailan AM; Liborio M; Lane SW; Paterson DL
    J Antimicrob Chemother; 2017 Mar; 72(3):668-677. PubMed ID: 27999023
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Outcomes of hospitalized neutropenic oncology patients with Pseudomonas aeruginosa bloodstream infections: focus on oral fluoroquinolone conversion.
    Yan LZ; Herrington JD
    J Oncol Pharm Pract; 2016 Aug; 22(4):584-90. PubMed ID: 26156260
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Incidence of septicaemias and invasive mycoses in children undergoing treatment for solid tumours: a 12-year experience at a single Italian institution.
    Haupt R; Romanengo M; Fears T; Viscoli C; Castagnola E
    Eur J Cancer; 2001 Dec; 37(18):2413-9. PubMed ID: 11720836
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Nosocomial bloodstream infections in children and adolescents in southern Israel: a 10-year prospective study (1992-2001).
    Frank M; Gur E; Givon-Lavi N; Peled N; Dagan R; Leibovitz E
    Scand J Infect Dis; 2005; 37(3):177-83. PubMed ID: 15849049
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical study of carbapenem sensitive and resistant Gram-negative bacteremia in neutropenic and nonneutropenic patients: The first series from India.
    Ghafur AK; Vidyalakshmi PR; Kannaian P; Balasubramaniam R
    Indian J Cancer; 2014; 51(4):453-5. PubMed ID: 26842159
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Bloodstream infections during the first year after pediatric small bowel transplantation.
    Florescu DF; Qiu F; Langnas AN; Mercer DF; Chambers H; Hill LA; Qaragholi N; Kalil AC
    Pediatr Infect Dis J; 2012 Jul; 31(7):700-4. PubMed ID: 22466325
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Association of secondary and polymicrobial nosocomial bloodstream infections with higher mortality.
    Pittet D; Li N; Wenzel RP
    Eur J Clin Microbiol Infect Dis; 1993 Nov; 12(11):813-9. PubMed ID: 8112351
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Trends in bacterial infections in febrile neutropenic patients: 1986-1992.
    Gibson J; Johnson L; Snowdon L; Joshua D; Young G; MacLeod C; Benn R; Iland H; Vincent P; Kronenberg H
    Aust N Z J Med; 1994 Aug; 24(4):374-7. PubMed ID: 7980233
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Surveillance of nosocomial infections in paediatric recipients of bone marrow or peripheral blood stem cell transplantation during neutropenia, compared with adult recipients.
    Laws HJ; Kobbe G; Dilloo D; Dettenkofer M; Meisel R; Geisel R; Haas R; Göbel U; Schulze-Röbbecke R
    J Hosp Infect; 2006 Jan; 62(1):80-8. PubMed ID: 16242206
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Bloodstream infection in paediatric cancer centres--leukaemia and relapsed malignancies are independent risk factors.
    Ammann RA; Laws HJ; Schrey D; Ehlert K; Moser O; Dilloo D; Bode U; Wawer A; Schrauder A; Cario G; Laengler A; Graf N; Furtwängler R; Simon A
    Eur J Pediatr; 2015 May; 174(5):675-86. PubMed ID: 25804192
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cure of implantable venous port-associated bloodstream infections in pediatric hematology-oncology patients without catheter removal.
    Rubin LG; Shih S; Shende A; Karayalcin G; Lanzkowsky P
    Clin Infect Dis; 1999 Jul; 29(1):102-5. PubMed ID: 10433571
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prospective Evaluation of Infection Episodes in Cancer Patients in a Tertiary Care Academic Center: Microbiological Features and Risk Factors for Mortality.
    Çalık Başaran N; Karaağaoğlu E; Hasçelik G; Durusu Tanrıöver M; Akova M
    Turk J Haematol; 2016 Dec; 33(4):311-319. PubMed ID: 27095391
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Bloodstream infections in organ transplant recipients receiving alemtuzumab: no evidence of occurrence of organisms typically associated with profound T cell depletion.
    Silveira FP; Marcos A; Kwak EJ; Husain S; Shapiro R; Thai N; McCurry KR; Abu-Elmagd K; Paterson DL
    J Infect; 2006 Oct; 53(4):241-7. PubMed ID: 16403576
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The clinical and prognostic importance of positive blood cultures in adults.
    Pien BC; Sundaram P; Raoof N; Costa SF; Mirrett S; Woods CW; Reller LB; Weinstein MP
    Am J Med; 2010 Sep; 123(9):819-28. PubMed ID: 20800151
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Bacteremia in children with tumors or malignant diseases 1991-2000].
    Alfredsdóttir IH; Thors VS; Gudnason T; Jónmundsson G; Kristinsson JR; Jónsson OG; Kristinsson KG; Haraldsson A
    Laeknabladid; 2008 Jul; 94(7-8):531-9. PubMed ID: 18591728
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Breakthrough bacteraemic and fungaemic episodes during antimicrobial prophylaxis and therapy in cancer patients: analysis of risk factors, etiology, therapy and outcome in 123 episodes.
    Spánik S; Krcméry V; Trupl J; Ilavská I; Hel'pianska L; Drgona L; Salek T; Mardiak J; Kukucková E; Studená M; Pichna P; Oravcová E; Grey E; Koren P; Minárik T; Lacka J; Sufliarsky J
    Bratisl Lek Listy; 1996 Nov; 97(11):652-9. PubMed ID: 9117428
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.